Vancouver Island Cardiac Arrhythmia Clinic
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Novak, Paul
OCEAN, NCT02168829 / 2016-002353-38: Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Active, not recruiting
4
1284
Europe, Canada, RoW
Rivaroxaban, Xarelto, Acetylsalicylic acid, Aspirin, ASA
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc
Atrial Fibrillation, Stroke
07/25
08/25
RAFT-PermAF, NCT01994252: Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation

Active, not recruiting
N/A
200
Canada
Optimal Medical therapy plus ICD, Optimal Medical therapy plus CRT/ICD
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
Heart Disease, Congestive Heart Failure, Atrial Fibrillation
09/24
09/24
STARAF3, NCT04428944: STrategies for Catheter Ablation of PeRsistent Atrial Fibrlllation

Active, not recruiting
N/A
617
Europe, Canada, Japan, US, RoW
Wide Circumferential Pulmonary Vein Antrum Isolation (PVAI), Pulmonary Vein Antrum Isolation Plus Driver Ablation (PVAI+drivers), Pulmonary Vein Antrum Isolation Plus Box Isolation of Posterior Wall (PVAI+box)
McGill University Health Centre/Research Institute of the McGill University Health Centre, Montreal Heart Institute
Atrial Fibrillation
09/27
12/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Novak, Paul
OCEAN, NCT02168829 / 2016-002353-38: Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Active, not recruiting
4
1284
Europe, Canada, RoW
Rivaroxaban, Xarelto, Acetylsalicylic acid, Aspirin, ASA
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc
Atrial Fibrillation, Stroke
07/25
08/25
RAFT-PermAF, NCT01994252: Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation

Active, not recruiting
N/A
200
Canada
Optimal Medical therapy plus ICD, Optimal Medical therapy plus CRT/ICD
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
Heart Disease, Congestive Heart Failure, Atrial Fibrillation
09/24
09/24
STARAF3, NCT04428944: STrategies for Catheter Ablation of PeRsistent Atrial Fibrlllation

Active, not recruiting
N/A
617
Europe, Canada, Japan, US, RoW
Wide Circumferential Pulmonary Vein Antrum Isolation (PVAI), Pulmonary Vein Antrum Isolation Plus Driver Ablation (PVAI+drivers), Pulmonary Vein Antrum Isolation Plus Box Isolation of Posterior Wall (PVAI+box)
McGill University Health Centre/Research Institute of the McGill University Health Centre, Montreal Heart Institute
Atrial Fibrillation
09/27
12/27

Download Options